• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

咖啡饮用与未经药物治疗的早期帕金森病非运动症状的关联。

Association of coffee consumption and non-motor symptoms in drug-naïve, early-stage Parkinson's disease.

机构信息

Department of Neurology, Chonnam National University Hospital, Gwangju, South Korea.

Department of Neurology, Chonnam National University Hospital, Gwangju, South Korea; National Research Center for Dementia, Gwangju, South Korea.

出版信息

Parkinsonism Relat Disord. 2018 May;50:42-47. doi: 10.1016/j.parkreldis.2018.02.016. Epub 2018 Feb 9.

DOI:10.1016/j.parkreldis.2018.02.016
PMID:29449185
Abstract

OBJECTIVE

Coffee consumption has an inverse association with the risk of Parkinson's disease (PD). The aim of this study was to investigate the association between coffee consumption and non-motor symptoms (NMSs) in patients with PD.

METHODS

In this cross-sectional study, we included 196 early-stage, treatment-naïve PD patients. Coffee consumption history was obtained via semi-structured interviews. NMSs were assessed using the Non-Motor Symptom assessment scale (NMSS).

RESULTS

Of the 196 patients with PD, 136 (69.3%) were categorized as coffee drinkers and 60 (30.6%) were non-drinkers. Coffee drinkers were younger, predominantly male, were younger in age at symptom onset, had lower Unified Parkinson's Disease Rating Scale motor and Beck Depression Inventory scores, and higher Mini-Mental State Examination scores than non-coffee drinkers. After adjustment, coffee drinking was significantly inversely associated with the prevalence of lack of motivation, anhedonia, and lack of pleasure, which were less frequent in coffee drinkers. Total NMSS scores were lower in coffee drinkers than in non-drinkers (p = 0.047). In particular, coffee drinking was significantly associated with a reduced severity of the mood/cognition domain of NMSS (p = 0.003). After correcting for multiple testing, there were no significant differences in the prevalence of NMSs, but there were significant differences in the severity of NMSs between coffee drinkers and non-drinkers.

CONCLUSION

There is a negative association between coffee consumption and the severity of the mood/cognition domain of NMSS in patients with PD. Clinicians should consider the history of coffee consumption in the assessment of NMSs in PD.

摘要

目的

咖啡的摄入与帕金森病(PD)的发病风险呈负相关。本研究旨在探讨咖啡摄入与 PD 患者非运动症状(NMSs)之间的关系。

方法

在这项横断面研究中,我们纳入了 196 例初诊、未经治疗的 PD 患者。通过半结构式访谈获取咖啡摄入史。使用非运动症状评估量表(NMSS)评估 NMSs。

结果

在 196 例 PD 患者中,136 例(69.3%)为咖啡饮用者,60 例(30.6%)为非饮用者。与非咖啡饮用者相比,咖啡饮用者更年轻、以男性为主,症状起始年龄更小,统一帕金森病评定量表运动评分和贝克抑郁量表评分更低,简易精神状态检查评分更高。调整后,咖啡摄入与缺乏动力、快感缺失和愉悦感缺乏的患病率呈显著负相关,咖啡饮用者中这些症状的发生率较低。咖啡饮用者的 NMSS 总分低于非饮用者(p=0.047)。特别是,咖啡摄入与 NMSS 情绪/认知域严重程度降低显著相关(p=0.003)。在进行多次检验校正后,两组 NMSs 的患病率无显著差异,但咖啡饮用者与非饮用者之间 NMSs 的严重程度存在显著差异。

结论

咖啡摄入与 PD 患者 NMSS 情绪/认知域的严重程度呈负相关。临床医生在评估 PD 患者的 NMSs 时应考虑咖啡摄入史。

相似文献

1
Association of coffee consumption and non-motor symptoms in drug-naïve, early-stage Parkinson's disease.咖啡饮用与未经药物治疗的早期帕金森病非运动症状的关联。
Parkinsonism Relat Disord. 2018 May;50:42-47. doi: 10.1016/j.parkreldis.2018.02.016. Epub 2018 Feb 9.
2
Gender-dependent effect of coffee consumption on tremor severity in de novo Parkinson's disease.咖啡摄入对新发帕金森病震颤严重程度的性别依赖性影响。
BMC Neurol. 2019 Aug 14;19(1):194. doi: 10.1186/s12883-019-1427-y.
3
Assessment of the Relationship between Non-motor features and Severity of Parkinson's Disease Patients in Bangladesh.孟加拉国非运动症状与帕金森病患者严重程度关系的评估。
Mymensingh Med J. 2023 Apr;32(2):463-475.
4
Evaluation of an Arabic version of the non-motor symptoms scale in Parkinson's disease.帕金森病非运动症状量表阿拉伯语版本的评估
Neurol Sci. 2016 Jun;37(6):963-8. doi: 10.1007/s10072-016-2525-x. Epub 2016 Mar 1.
5
Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.ADAGIO 研究中帕金森病中联合使用雷沙吉兰和抗抑郁药:对非运动症状和耐受性的影响。
JAMA Neurol. 2015 Jan;72(1):88-95. doi: 10.1001/jamaneurol.2014.2472.
6
Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.帕金森病非运动症状对健康相关和感知生活质量的影响。
J Neurol Sci. 2013 Sep 15;332(1-2):136-40. doi: 10.1016/j.jns.2013.07.005. Epub 2013 Jul 25.
7
Validation of the Italian version of the Non Motor Symptoms Scale for Parkinson's disease.帕金森病非运动症状量表意大利语版本的验证
Parkinsonism Relat Disord. 2017 Jan;34:38-42. doi: 10.1016/j.parkreldis.2016.10.020. Epub 2016 Oct 24.
8
Nonmotor symptoms of 820 Taiwanese patients with Parkinson's disease: an exploratory-comparative study.820 例台湾帕金森病患者的非运动症状:一项探索性比较研究。
J Neurol. 2020 May;267(5):1499-1507. doi: 10.1007/s00415-020-09708-4. Epub 2020 Feb 5.
9
Quantitative assessment of non-motor fluctuations in Parkinson's disease using the Non-Motor Symptoms Scale (NMSS).使用非运动症状量表(NMSS)对帕金森病非运动波动进行定量评估。
J Neural Transm (Vienna). 2015 Dec;122(12):1673-84. doi: 10.1007/s00702-015-1437-x. Epub 2015 Aug 12.
10
The impact of non-motor symptoms on the quality of life of Parkinson's disease patients: a longitudinal study.非运动症状对帕金森病患者生活质量的影响:一项纵向研究。
Eur J Neurol. 2016 May;23(5):854-60. doi: 10.1111/ene.12950. Epub 2016 Jan 25.

引用本文的文献

1
Exploring Risk and Protective Factors in Parkinson's Disease.探索帕金森病的风险因素和保护因素。
Cells. 2025 May 14;14(10):710. doi: 10.3390/cells14100710.
2
German Society of Neurology guidelines for the diagnosis and treatment of cognitive impairment and affective disorders in people with Parkinson's disease: new spotlights on diagnostic procedures and non-pharmacological interventions.德国神经病学会关于帕金森病患者认知障碍和情感障碍的诊断和治疗指南:诊断程序和非药物干预的新重点。
J Neurol. 2024 Nov;271(11):7330-7357. doi: 10.1007/s00415-024-12503-0. Epub 2024 Aug 9.
3
Exploiting Natural Niches with Neuroprotective Properties: A Comprehensive Review.
利用具有神经保护特性的自然生态位:全面综述。
Nutrients. 2024 Apr 26;16(9):1298. doi: 10.3390/nu16091298.
4
Does dietary intake of caffeine have an effect on transient global amnesia?饮食中摄入咖啡因会对短暂性全面性遗忘症产生影响吗?
Neuropsychopharmacol Rep. 2024 Mar;44(1):143-148. doi: 10.1002/npr2.12408. Epub 2023 Dec 22.
5
Targeting the adenosine A receptor for neuroprotection and cognitive improvement in traumatic brain injury and Parkinson's disease.针对创伤性脑损伤和帕金森病的神经保护和认知改善的腺苷 A 受体。
Chin J Traumatol. 2024 May;27(3):125-133. doi: 10.1016/j.cjtee.2023.08.003. Epub 2023 Aug 25.
6
Prevention of Parkinson's Disease: From Risk Factors to Early Interventions.帕金森病的预防:从危险因素到早期干预。
CNS Neurol Disord Drug Targets. 2024;23(6):746-760. doi: 10.2174/1871527322666230616092054.
7
Lifestyle factors and clinical severity of Parkinson's disease.生活方式因素与帕金森病的临床严重程度。
Sci Rep. 2023 Jun 12;13(1):9537. doi: 10.1038/s41598-023-31531-w.
8
Apathy in Parkinson's Disease: Defining the Park Apathy Subtype.帕金森病中的淡漠:定义帕金森淡漠亚型
Brain Sci. 2022 Jul 14;12(7):923. doi: 10.3390/brainsci12070923.
9
The Pharmacological Potential of Adenosine A Receptor Antagonists for Treating Parkinson's Disease.腺苷 A 受体拮抗剂治疗帕金森病的药理学潜力。
Molecules. 2022 Apr 6;27(7):2366. doi: 10.3390/molecules27072366.
10
Self-Reported Visual Complaints in People with Parkinson's Disease: A Systematic Review.帕金森病患者的自述视觉主诉:系统评价。
J Parkinsons Dis. 2022;12(3):785-806. doi: 10.3233/JPD-202324.